2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with adenosine monophosphate in 1 studies
| Studies (2-hexynyladenosine-5'-n-ethylcarboxamide) | Trials (2-hexynyladenosine-5'-n-ethylcarboxamide) | Recent Studies (post-2010) (2-hexynyladenosine-5'-n-ethylcarboxamide) | Studies (adenosine monophosphate) | Trials (adenosine monophosphate) | Recent Studies (post-2010) (adenosine monophosphate) |
|---|---|---|---|---|---|
| 28 | 0 | 2 | 11,432 | 257 | 2,798 |
| Protein | Taxonomy | 2-hexynyladenosine-5'-n-ethylcarboxamide (IC50) | adenosine monophosphate (IC50) |
|---|---|---|---|
| Fructose-1,6-bisphosphatase 1 | Sus scrofa (pig) | 1.3 | |
| Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | 2.6436 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.6 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.1 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.44 | |
| Histamine H3 receptor | Rattus norvegicus (Norway rat) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonda, TA; Karolczak, K; Kramkowski, K; Polak, D; Przygodzki, T; Talar, M; Watala, C; Wojkowska, DW; Wolska, N | 1 |
1 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and adenosine monophosphate
| Article | Year |
|---|---|
Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in vivo by Decreasing of Fibrinogen Density in Thrombus.
Topics: Adenosine Monophosphate; Adenosine-5'-(N-ethylcarboxamide); Adult; Animals; Antithrombins; Blood Pressure; Blood-Brain Barrier; Chlorides; Diastole; Female; Ferric Compounds; Fibrinogen; Humans; Laser-Doppler Flowmetry; Male; Mice, Inbred C57BL; Permeability; Platelet Activation; Platelet Aggregation; Prasugrel Hydrochloride; Purinergic P1 Receptor Agonists; Purinergic P2Y Receptor Antagonists; Systole; Thrombosis | 2021 |